Transition at Teva - Blockbuster Drug Copaxone to Lose Patent Protection in 2014

Blockbuster History in the New Russia
Por: Norris

Blockbuster, Inc. SWOT Analysis

Teva Pharmaceutical Industries SWOT Analysis

The Shame of Losing
Por: Cannon

Losing Beck
Por: Hahn

Losing Ground
Por: Burley

Losing the Center
Por: Bloodworth

Losing Vietnam
Por: Hunt

Nothing to Lose
Por: Sanderson

Free to lose.
Por: Roemer, John E
Publicado em: (1988)

The art of losing.
Por: Zeniter, Alice
Publicado em: (2021)

Free to lose.
Por: Roemer, John E
Publicado em: (1988)

India and the Patent Wars
Por: Halliburton

World Patent Information

Pharmaceutical Patent Analyst

Teva Pharmaceutical Industries Limited SWOT Analysis

Expert Opinion on Therapeutic Patents

Losing Touch with Nature
Por: Crane

So Much to Lose
Por: Rust

Losing Binh Dinh
Por: Boylan

Losing Hearts and Minds
Por: Shannon

Just Who Loses?
Por: Lucas

Winning While Losing
Por: White

Losing america : confronting a reckless and arrogant presidency /
Por: Byrd, Senator Robert C.
Publicado em: (2004)

Letters Patent to John Cabot, 1496

Letters Patent to John Cabot, 1496

Teva Pharmaceutical Industries Limited MarketLine Company Profile

Teva Case Study: Building a Growing Share of the Generics Market

Reports of Patent, Design and Trade Mark Cases

In Transit
Por: Kleeman

Transition

Transitions

Transitions
Por: Sarat

Transit
Por: Ball

Transition

Proceedings of the 4th workshop on Patent information retrieval